The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of predictive impact of MGMT promoter methylation in malignant astrocytomas depends on the methylation subgroup.
 
Wolfgang Wick
Consulting or Advisory Role - Abbvie
Research Funding - Apogenix (Inst); Pfizer (Inst); Roche (Inst)
 
Tobias Kessler
No Relationships to Disclose
 
Michael Platten
Honoraria - Merck; Novartis; Roche
Consulting or Advisory Role - Bayer (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst)
Research Funding - Bayer (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Diagnosing and treating IDH1-mutant cancers; Treating cancers with AHR antagonists; Treating H3.3K27M-mutant cancers
Travel, Accommodations, Expenses - Merck; Novartis; Roche
 
Christoph Meisner
No Relationships to Disclose
 
Michael Bamberg
No Relationships to Disclose
 
Ulrich Herrlinger
No Relationships to Disclose
 
Caroline Happold
No Relationships to Disclose
 
Sarah Weisang
No Relationships to Disclose
 
Hanna Boelting
No Relationships to Disclose
 
Joachim Steinbach
No Relationships to Disclose
 
Guido Reifenberger
No Relationships to Disclose
 
Felix Sahm
No Relationships to Disclose
 
Andreas von Deimling
Research Funding - Bayer
Patents, Royalties, Other Intellectual Property - Patent for BRAFV600E antibody VE1 administered by the German Cancer Center (DKFZ); Patent for IDH1R132H antibody H09 administered by the German Cancer Center (DKFZ)
Travel, Accommodations, Expenses - Roche
 
Antje Wick
No Relationships to Disclose
 
Michael Weller
Honoraria - Merck Serono; MSD; Novocure; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Merck Serono; Orbus Therapeutics; Pfizer; Teva; Tocagen
Research Funding - Bayer (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); OGD2 Pharma (Inst); Piqur (Inst); Roche (Inst); Tragara (Inst)